Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin problems.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

COVID-19 can cause temporary hair loss due to stress and inflammation.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Maidenhair fern extract might help treat COVID-19 symptoms, but more research is needed.

The pandemic stress may have increased alopecia cases in Bangladesh.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Maidenhair fern extract may help treat COVID-19 symptoms.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Lower Gas6 and sAxl levels are linked to hair loss in COVID-19 survivors.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.